6-K 1 dp55492_6k.htm FORM 6-K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 6-K
 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934


For the month of April, 2015
 
 
Commission File Number: 001-13742

ISRAEL CHEMICALS LTD.
(Exact name of registrant as specified in its charter)

Israel Chemicals Ltd.
Millennium Tower
23 Aranha Street
P.O. Box 20245
Tel Aviv, 61202 Israel
(972-3) 684-4400
(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F
X
  
Form 40-F
  

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

Yes
    
No
X

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

Yes
    
No
X

 
 
 
 
 
 
ISRAEL CHEMICALS LTD.

1.  
Immediate Report Regarding the Sale of Potash to Customers in China (April 23, 2015)
 
 
 
 
 

Item 1
 
 
Immediate Report Regarding the Sale of Potash to Customers in China
 
The Company wishes to announce that it completed yesterday the signature of agreements to supply its customers in China with an aggregate 1.1 million metric tons of potash during 2015. The agreements include options for additional 100,000 metric tons of potash. According to the terms of the agreements, the selling price for the first half of the year will be in line with the prevailing market price in China (this reflects an increase of $10 per metric ton).
 
According to the contracts, which are part of three-year framework agreements between ICL and its customers in China, most of the quantities which the Company will be unable to supply during the first half of 2015 as a result of the strike at ICL Dead Sea, will be delivered during the second half of the year.


 

 
 
 
 
 

SIGNATURE


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 

   
Israel Chemicals Ltd.
  
       
       
     
By:
/s/ Kobi Altman
  
       
Name:
Kobi Altman
  
       
Title:
Executive Vice President and Chief Financial Officer
  

   
Israel Chemicals Ltd.
  
       
       
     
By:
/s/ Lisa Haimovitz
  
       
Name:
Lisa Haimovitz
  
       
Title:
Vice President, General Counsel and Corporate Secretary
  

Date: April 23, 2015